Statins: underused by those who would benefit

Hulley, Stephen B; Grady, Deborah; Browner, Warren S
October 2000
BMJ: British Medical Journal (International Edition);10/21/2000, Vol. 321 Issue 7267, p971
Academic Journal
Editorial. Argues that the over-the-counter sale of statins would increase their use as a preventative measure against heart disease. Benefits of statins for patients with atherosclerotic disease; Impact of statin undertreatment on populations at risk for coronary disease; Guidelines for drug treatment using statins; Concerns regarding the safety and cost of the drugs; Outlook for the removal of obstacles to widespread statin use.


Related Articles

  • Tailored statin regime best for cuttina coronary events.  // Pulse;1/27/2010, Vol. 70 Issue 2, p10 

    The article reports on the U.S. study which found that tailored statin therapy for patients with high coronary artery disease (CAD) risk is effective in preventing coronary events than treating to a cholesterol target.

  • Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy. Berto, P.; Munro, V.; Gaddi, A.; Negrini, C.; Hutton, J.; Mast, O. // Clinical Drug Investigation;2000, Vol. 20 Issue 2, p109 

    Objective: The objective of this analysis was to compare the costs, benefits and cost effectiveness of two dosage regimens of cerivastatin (0.2 and 0.4 mg/day) with Italian National Health Service (NHS) reimbursed comparative statins in the primary prevention of coronary heart disease in Italy....

  • Effective Use of Statins to Prevent Coronary Heart Disease. Crouch, Michael A. // American Family Physician;01/15/2001, Vol. 63 Issue 2, p309 

    Presents information on a study which determined the effectiveness of statins in preventing coronary heart disease. Overview of prevention; Pharmacologic treatment; Cost-effectiveness of statin treatment.

  • Statins for Primary Prevention in Older Adults.  // Annals of Internal Medicine;4/20/2015, Vol. 162 Issue 8, pI-28 

    The article presents several question and answers related to statins for primary prevention in older adults including prevention of heart disease, study on statins, and clinical trials on statins.

  • Many Still Favor Brand-Name Statins.  // Chain Drug Review;2/22/2016, Vol. 38 Issue 4, p53 

    The article discusses consumer health care website Treato's first annual list of top statins, medications to treat high cholesterol and reduce the risk of heart disease, including Merck & Co.'s Vytorin and lovastatin and Bristol Myers Squibb Co.'s Pravachol.

  • Highlights.  // Clinical Pharmacology & Therapeutics;Apr2012, Vol. 91 Issue 4, p568 

    The article offers news briefs related to pharmacology. It notes the health benefits and advantages of glycoconjugate vaccines which have been developed to protect against important bacterial pathogens. It describes the mechanics of tumor cell behavior which notes that mechanical compression...

  • FDA Drug Approvals: Crestor.  // Formulary;Sep2003, Vol. 38 Issue 9, p509 

    Offers information on the pharmacology of the resuvastatin drug Crestor. Approval for treatment of lipid disorders; Performance of the drug in the treatment of patients with hypercholesterolemia; Contraindication of resuvastatin in liver disease or persistent elevations of serum transaminases.

  • Statin Use in Patients with Abnormal Liver Function.  // Internal Medicine Alert;1/15/2011 Clinical Briefs, p1 

    The article offers pharmacology updates focusing on a recent study which shows that statins can improve liver abnormalities in patients with fatty liver.

  • The JUPITER trial and statins in primary prevention: Unequivocal benefit, or still a debatable issue? Tota-Maharaj, Rajesh; Blaha, Michael J.; Blumenthal, Roger S. // Cardiology Today;Dec2010, Vol. 13 Issue 12, p4 

    The authors comment on the debate over statins as part of the standard of care for secondary prevention of coronary heart disease (CHD).


Read the Article


Sign out of this library

Other Topics